The Europe Topical Scar Treatment Market would witness market growth of 8.9% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,776 million by 2030. The UK market is exhibiting a CAGR of 7.9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.8% during (2023 - 2030).
Nanotechnology is increasingly being applied to skincare, including scar treatment. Nano-sized particles can increase the penetration of active substances, allowing for improved absorption into the skin and possibly enhancing treatment outcomes. The concept of personalized skincare extends to scar treatment. Some companies are exploring developing products customized to an individual’s skin type, scar severity, and specific needs.
Stretch marks can be treated with topical products designed to improve skin elasticity and lower the appearance of lines and discoloration. These are sometimes prophylactically to minimize scarring after surgery or injury. Early application of these treatments during wound healing can help prevent excessive scar formation. Even scars that have been present for a long time can benefit from topical scar treatments.
As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,776 million by 2030. The UK market is exhibiting a CAGR of 7.9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.8% during (2023 - 2030).
Nanotechnology is increasingly being applied to skincare, including scar treatment. Nano-sized particles can increase the penetration of active substances, allowing for improved absorption into the skin and possibly enhancing treatment outcomes. The concept of personalized skincare extends to scar treatment. Some companies are exploring developing products customized to an individual’s skin type, scar severity, and specific needs.
Stretch marks can be treated with topical products designed to improve skin elasticity and lower the appearance of lines and discoloration. These are sometimes prophylactically to minimize scarring after surgery or injury. Early application of these treatments during wound healing can help prevent excessive scar formation. Even scars that have been present for a long time can benefit from topical scar treatments.
As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
Market Report Segmentation
By End-use- Hospitals
- Clinics
- Homecare
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
- Creams
- Gels
- Silicon Sheets
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Topical Scar Treatment Market by End-use
Chapter 5. Europe Topical Scar Treatment Market by Scar Type
Chapter 6. Europe Topical Scar Treatment Market by Product
Chapter 7. Europe Topical Scar Treatment Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
Methodology
LOADING...
